Renal Insufficiency Has No Effect on the Pharmacokinetics of Vicriviroc in a Ritonavir-Containing Regimen

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.49, Iss.6, 2010-06, pp. : 397-406

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Ritonavir-Containing Regimens on Lipids Compared to Other Protease Inhibitors

By Segarra-Newnham Marisel Haselkorn Susan M.

Journal of Infectious Disease Pharmacotherapy, Vol. 6, Iss. 3, 2004-01 ,pp. : 37-45

Haworth Press

Access to resources Recommend Favorite

Pharmacokinetics of Troglitazone in Patients with Renal Insufficiency

By Knowlton P.W.

Clinical Drug Investigation, Vol. 17, Iss. 2, 1999-02 ,pp. : 127-136

Adis International

Access to resources Recommend Favorite

RAD-containing regimen has potential in lung transplantation

Inpharma, Vol. 1, Iss. 1234, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Quinupristin/ Dalfopristin in Patients with Severe Chronic Renal Insufficiency

By Chevalier P.

Clinical Pharmacokinetics, Vol. 39, Iss. 1, 2000-07 ,pp. : 77-84

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of the BEACOPP Polychemotherapy Regimen in Hodgkin's Lymphoma and its Effect on Myelotoxicity

By Wilde Stefan

Clinical Pharmacokinetics, Vol. 46, Iss. 4, 2007-01 ,pp. : 319-333

Adis International

Access to resources Recommend Favorite